M.J. Biopharm is a fully integrated biopharmaceutical company offering human insulin, analogue insulin, GLP1 agents, both as drug substance and formulations. M.J. offers partnering opportunities in development and commercialisation of generic products. Our process development expertise is from proof of concept to commercial scale and yield optimisation. We also offer contract manufacturing in vials, ampoules, cartridges and disposable pens. Contact email address: linkedin@mjbiopharm.com